n contributes to the pathogenesis of preeclampsia. Nat Med, 2006. 12(6): p. 642-9.РLevine, R.J., et al., Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med, 2006. 355(10): p. 992-1005.РVerlohren, S., et al., The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol. 206(1): p. 58 e1-8.РOhkuchi, A., et al., Threshold of soluble fms-like tyrosine kinase 1/placental growth factor ratio for the imminent onset of preeclampsia. Hypertension. 58(5): p. 859-66.РDaponte, A., et al., Soluble FMS-like tyrosine kinase-1 (sFlt-1) and serum placental growth factor (PlGF) as biomarkers for ectopic pregnancy and missed abortion. J Clin Endocrinol Metab. 96(9): p. E1444-51.
全文预览
